Skip to main content
NCBI home page
Journal of the Royal Society of Medicine logoLink to Journal of the Royal Society of Medicine
. 1986;79(Suppl 12):19–22.

Viral infection in cystic fibrosis.

J Stroobant
PMCID: PMC1290121  PMID: 3522911

Full text

PDF
19

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aherne W., Bird T., Court S. D., Gardner P. S., McQuillin J. Pathological changes in virus infections of the lower respiratory tract in children. J Clin Pathol. 1970 Feb;23(1):7–18. doi: 10.1136/jcp.23.1.7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Boxerbaum B. The art and science of the use of antibiotics in cystic fibrosis. Pediatr Infect Dis. 1982 Nov-Dec;1(6):381–383. doi: 10.1097/00006454-198211000-00003. [DOI] [PubMed] [Google Scholar]
  3. CARILLI A. D., GOHD R. S., GORDON W. A VIROLOGIC STUDY OF CHRONIC BRONCHITIS. N Engl J Med. 1964 Jan 16;270:123–127. doi: 10.1056/NEJM196401162700303. [DOI] [PubMed] [Google Scholar]
  4. Efthimiou J., Hodson M. E., Taylor P., Taylor A. G., Batten J. C. Importance of viruses and Legionella pneumophila in respiratory exacerbations of young adults with cystic fibrosis. Thorax. 1984 Feb;39(2):150–154. doi: 10.1136/thx.39.2.150. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Fainstein V., Musher D. M., Cate T. R. Bacterial adherence to pharyngeal cells during viral infection. J Infect Dis. 1980 Feb;141(2):172–176. doi: 10.1093/infdis/141.2.172. [DOI] [PubMed] [Google Scholar]
  6. Fainstein V., Musher D. M., Cate T. R. Bacterial adherence to pharyngeal cells during viral infection. J Infect Dis. 1980 Feb;141(2):172–176. doi: 10.1093/infdis/141.2.172. [DOI] [PubMed] [Google Scholar]
  7. Fishaut M., Tubergen D., McIntosh K. Cellular response to respiratory viruses with particular reference to children with disorders of cell-mediated immunity. J Pediatr. 1980 Feb;96(2):179–186. doi: 10.1016/s0022-3476(80)80799-2. [DOI] [PubMed] [Google Scholar]
  8. Green G. M., Jakab G. J., Low R. B., Davis G. S. Defense mechanisms of the respiratory membrane. Am Rev Respir Dis. 1977 Mar;115(3):479–514. doi: 10.1164/arrd.1977.115.3.479. [DOI] [PubMed] [Google Scholar]
  9. Gwaltney J. M., Jr, Sande M. A., Austrian R., Hendley J. O. Spread of Streptococcus pneumoniae in families. II. Relation of transfer of S. pneumoniae to incidence of colds and serum antibody. J Infect Dis. 1975 Jul;132(1):62–68. doi: 10.1093/infdis/132.1.62. [DOI] [PubMed] [Google Scholar]
  10. HUANG N. N., VAN LOON E. L., SHENG K. T. The flora of the respiratory tract of patients with cystic fibrosis of the pancreas. J Pediatr. 1961 Oct;59:512–521. doi: 10.1016/s0022-3476(61)80234-5. [DOI] [PubMed] [Google Scholar]
  11. Horn M. E., Brain E. A., Gregg I., Inglis J. M., Yealland S. J., Taylor P. Respiratory viral infection and wheezy bronchitis in childhood. Thorax. 1979 Feb;34(1):23–28. doi: 10.1136/thx.34.1.23. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Isaacs D., Clarke J. R., Tyrrell D. A., Valman H. B. Selective infection of lower respiratory tract by respiratory viruses in children with recurrent respiratory tract infections. Br Med J (Clin Res Ed) 1982 Jun 12;284(6331):1746–1748. doi: 10.1136/bmj.284.6331.1746. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Marks M. I. Respiratory viruses in cystic fibrosis. N Engl J Med. 1984 Dec 27;311(26):1695–1696. doi: 10.1056/NEJM198412273112610. [DOI] [PubMed] [Google Scholar]
  14. Marks M. I. The pathogenesis and treatment of pulmonary infections in patients with cystic fibrosis. J Pediatr. 1981 Feb;98(2):173–179. doi: 10.1016/s0022-3476(81)80631-2. [DOI] [PubMed] [Google Scholar]
  15. Maxwell D. The role of antibiotics given by inhalation in chronic chest disease. J Antimicrob Chemother. 1983 Mar;11(3):203–206. doi: 10.1093/jac/11.3.203. [DOI] [PubMed] [Google Scholar]
  16. McNamara M. J., Phillips I. A., Williams O. B. Viral and Mycoplasma pneumoniae infections in exacerbations of chronic lung disease. Am Rev Respir Dis. 1969 Jul;100(1):19–24. doi: 10.1164/arrd.1969.100.1.19. [DOI] [PubMed] [Google Scholar]
  17. Merigan T. C., Reed S. E., Hall T. S., Tyrrell D. A. Inhibition of respiratory virus infection by locally applied interferon. Lancet. 1973 Mar 17;1(7803):563–567. doi: 10.1016/s0140-6736(73)90714-9. [DOI] [PubMed] [Google Scholar]
  18. Nichol K. P., Cherry J. D. Bacterial-viral interrelations in respiratory infections of children. N Engl J Med. 1967 Sep 28;277(13):667–672. doi: 10.1056/NEJM196709282771301. [DOI] [PubMed] [Google Scholar]
  19. Oxford J. S. Future prospects. Br Med Bull. 1985 Oct;41(4):396–400. doi: 10.1093/oxfordjournals.bmb.a072083. [DOI] [PubMed] [Google Scholar]
  20. Paisley J. W., Lauer B. A., McIntosh K., Glode M. P., Schachter J., Rumack C. Pathogens associated with acute lower respiratory tract infection in young children. Pediatr Infect Dis. 1984 Jan-Feb;3(1):14–19. doi: 10.1097/00006454-198401000-00005. [DOI] [PubMed] [Google Scholar]
  21. Penketh A., Pitt T., Roberts D., Hodson M. E., Batten J. C. The relationship of phenotype changes in Pseudomonas aeruginosa to the clinical condition of patients with cystic fibrosis. Am Rev Respir Dis. 1983 May;127(5):605–608. doi: 10.1164/arrd.1983.127.5.605. [DOI] [PubMed] [Google Scholar]
  22. Petersen N. T., Høiby N., Mordhorst C. H., Lind K., Flensborg E. W., Bruun B. Respiratory infections in cystic fibrosis patients caused by virus, chlamydia and mycoplasma--possible synergism with Pseudomonas aeruginosa. Acta Paediatr Scand. 1981 Sep;70(5):623–628. doi: 10.1111/j.1651-2227.1981.tb05757.x. [DOI] [PubMed] [Google Scholar]
  23. Reed W. P., Williams R. C., Jr Bacterial adherence: first step in pathogenesis of certain infections. J Chronic Dis. 1978 Feb;31(2):67–72. doi: 10.1016/0021-9681(78)90091-7. [DOI] [PubMed] [Google Scholar]
  24. Schiøtz P. O., Jørgensen M., Flensborg E. W., Faerø O., Husby S., Høiby N., Jacobsen S. V., Nielsen H., Svehag S. E. Chronic Pseudomonas aeruginosa lung infection in cystic fibrosis. A longitudinal study of immune complex activity and inflammatory response in sputum sol-phase of cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infections: influence of local steroid treatment. Acta Paediatr Scand. 1983 Mar;72(2):283–287. doi: 10.1111/j.1651-2227.1983.tb09712.x. [DOI] [PubMed] [Google Scholar]
  25. Scott G. M., Phillpotts R. J., Wallace J., Gauci C. L., Greiner J., Tyrrell D. A. Prevention of rhinovirus colds by human interferon alpha-2 from Escherichia coli. Lancet. 1982 Jul 24;2(8291):186–188. doi: 10.1016/s0140-6736(82)91031-5. [DOI] [PubMed] [Google Scholar]
  26. Wang E. E., Prober C. G., Manson B., Corey M., Levison H. Association of respiratory viral infections with pulmonary deterioration in patients with cystic fibrosis. N Engl J Med. 1984 Dec 27;311(26):1653–1658. doi: 10.1056/NEJM198412273112602. [DOI] [PubMed] [Google Scholar]
  27. Wright P. F., Khaw K. T., Oxman M. N., Shwachman H. Evaluation of the safety of amantadine-HC1 and the role of respiratory viral infections in children with cystic fibrosis. J Infect Dis. 1976 Aug;134(2):144–149. doi: 10.1093/infdis/134.2.144. [DOI] [PubMed] [Google Scholar]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press

RESOURCES